JP2017528457A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017528457A5 JP2017528457A5 JP2017512783A JP2017512783A JP2017528457A5 JP 2017528457 A5 JP2017528457 A5 JP 2017528457A5 JP 2017512783 A JP2017512783 A JP 2017512783A JP 2017512783 A JP2017512783 A JP 2017512783A JP 2017528457 A5 JP2017528457 A5 JP 2017528457A5
- Authority
- JP
- Japan
- Prior art keywords
- dosage form
- unit dosage
- abiraterone acetate
- dose
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462052294P | 2014-09-18 | 2014-09-18 | |
| US62/052,294 | 2014-09-18 | ||
| US14/707,922 US20150246060A1 (en) | 2013-03-15 | 2015-05-08 | Abiraterone Acetate Formulation and Methods of Use |
| US14/707,922 | 2015-05-08 | ||
| PCT/US2015/050889 WO2016044701A1 (en) | 2014-09-18 | 2015-09-18 | Abiraterone acetate formulation and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017528457A JP2017528457A (ja) | 2017-09-28 |
| JP2017528457A5 true JP2017528457A5 (enrdf_load_stackoverflow) | 2018-10-18 |
Family
ID=55533897
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017512783A Pending JP2017528457A (ja) | 2014-09-18 | 2015-09-18 | 酢酸アビラテロン製剤及び使用方法 |
Country Status (17)
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2863500T3 (es) | 2015-04-10 | 2021-10-11 | Capsugel Belgium Nv | Formulaciones lipídicas de acetato de abiraterona |
| EP3606506A4 (en) * | 2017-04-07 | 2021-01-06 | MAA Laboratories, Inc. | PROCESSES FOR IMPROVING THE SOLUBILITY AND BIOAVAILABILITY OF THERAPEUTIC AGENTS |
| WO2020151633A1 (en) * | 2019-01-25 | 2020-07-30 | Shenzhen Pharmacin Co., Ltd. | Pharmaceutical compositions |
| IL286048B2 (en) | 2019-03-06 | 2025-03-01 | Propella Therapeutics Inc | Abiraterone decanoate and its pharmaceutical salts, pharmaceutical preparations containing them, their uses and preparation |
| CN110742870B (zh) * | 2019-12-04 | 2021-04-20 | 武汉大学 | 醋酸阿比特龙制剂及其制备方法 |
| CN111110646A (zh) * | 2020-02-19 | 2020-05-08 | 纳兰迦(上海)生物医药科技有限公司 | 一种低规格醋酸阿比特龙口服制剂的处方及制备方法 |
| CN113384542B (zh) * | 2020-03-14 | 2024-03-29 | 鲁南制药集团股份有限公司 | 一种甾体cyp17抑制剂固体分散体的片剂及其制备方法 |
| CN115427016A (zh) * | 2020-04-16 | 2022-12-02 | 塔凡塔医疗匈牙利公司 | 用于治疗前列腺癌的方法和组合物 |
| UY39201A (es) * | 2020-05-08 | 2021-11-30 | Janssen Pharmaceutica Nv | Tratamientos del cáncer de próstata con combinaciones de acetato de abiraterona y niraparib |
| EP3944860A1 (en) | 2020-07-30 | 2022-02-02 | Galenicum Health S.L.U. | Abiraterone for use in a method of treating cancer |
| US11957696B2 (en) | 2021-02-15 | 2024-04-16 | Propella Therapeutics, Inc. | Abiraterone prodrugs |
| KR20240044329A (ko) | 2022-09-28 | 2024-04-04 | 한미약품 주식회사 | 아비라테론 아세테이트 및 프레드니솔론을 포함하는 경구용 복합정제 |
| KR20240145412A (ko) | 2023-03-27 | 2024-10-07 | 한미약품 주식회사 | 아비라테론 아세테이트 및 프레드니솔론을 포함하는 약제학적 제제 및 이의 제조방법 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY177537A (en) * | 2009-04-24 | 2020-09-17 | Iceutica Pty Ltd | Production of encapsulated nanoparticles at commercial scale |
| GB201207886D0 (en) * | 2012-05-04 | 2012-06-20 | Jagotec Ag | Improvements in or relating to organic compounds |
| WO2014009434A1 (en) | 2012-07-11 | 2014-01-16 | Sandoz Ag | Self-microemulsifying drug delivery system of abiraterone or abiraterone acetate |
| WO2014009437A1 (en) * | 2012-07-11 | 2014-01-16 | Sandoz Ag | Oxidation stability of abiraterone acetate |
| WO2014009436A1 (en) * | 2012-07-11 | 2014-01-16 | Sandoz Ag | Nanosuspension of abiraterone acetate |
| CN102743393A (zh) | 2012-07-27 | 2012-10-24 | 海南盛科生命科学研究院 | 一种含有醋酸阿比特龙的药物组合物及制备工艺 |
| SG10201709400VA (en) | 2013-03-15 | 2018-01-30 | Iceutica Inc | Abiraterone acetate formulation |
-
2015
- 2015-09-18 BR BR112017003219A patent/BR112017003219A2/pt not_active IP Right Cessation
- 2015-09-18 CN CN201580050453.8A patent/CN106687112A/zh active Pending
- 2015-09-18 MD MDA20170048A patent/MD20170048A2/ro not_active Application Discontinuation
- 2015-09-18 CA CA2958316A patent/CA2958316A1/en active Pending
- 2015-09-18 EP EP15842591.8A patent/EP3193857A4/en not_active Withdrawn
- 2015-09-18 EA EA201790650A patent/EA201790650A1/ru unknown
- 2015-09-18 WO PCT/US2015/050889 patent/WO2016044701A1/en active Application Filing
- 2015-09-18 TN TNP/2018/000318A patent/TN2018000318A1/en unknown
- 2015-09-18 JP JP2017512783A patent/JP2017528457A/ja active Pending
- 2015-09-18 KR KR1020177008938A patent/KR102491439B1/ko active Active
- 2015-09-18 SG SG11201701139YA patent/SG11201701139YA/en unknown
- 2015-09-18 KR KR1020237001893A patent/KR102617537B1/ko active Active
- 2015-09-18 AP AP2017009804A patent/AP2017009804A0/en unknown
- 2015-09-18 MX MX2017003525A patent/MX2017003525A/es unknown
- 2015-09-18 TN TN2017000098A patent/TN2017000098A1/en unknown
- 2015-09-18 AU AU2015317466A patent/AU2015317466A1/en not_active Abandoned
-
2017
- 2017-01-25 IL IL250270A patent/IL250270B/en active IP Right Grant
- 2017-02-09 PH PH12017500239A patent/PH12017500239A1/en unknown
- 2017-03-15 CO CONC2017/0002472A patent/CO2017002472A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017528457A5 (enrdf_load_stackoverflow) | ||
| JP3145111B2 (ja) | 炎症性腸疾患処置用経口組成物 | |
| EP2482822B1 (en) | Orally administered corticosteroid compositions | |
| JP2015531400A (ja) | プロゲステロン含有経口投与形態およびキット | |
| WO2003000263A1 (en) | Rapid onset formulation | |
| AU2001272243A1 (en) | Rapid onset formulation | |
| JP2020530832A (ja) | 副腎皮質刺激ホルモン放出因子受容体拮抗薬 | |
| EP3911304A1 (en) | Modified release tablet formulations containing phosphodiesterase inhibitors | |
| WO2013134348A1 (en) | Controlled-release solid dosage forms of mesalamine | |
| WO2021129735A1 (zh) | 一种固体制剂及其制备方法和用途 | |
| JP2017517551A5 (enrdf_load_stackoverflow) | ||
| CN103316026B (zh) | 含芬特明和托吡酯的联合产品及其制备方法 | |
| JP2010538062A5 (enrdf_load_stackoverflow) | ||
| JP2011506607A5 (enrdf_load_stackoverflow) | ||
| EP2110130A1 (en) | Pharmaceutical use of 6-mercaptopurine | |
| JP2007529564A5 (enrdf_load_stackoverflow) | ||
| EP3441064B1 (en) | Extended release liquid compositions of guaifenesin | |
| WO2017100246A1 (en) | Pharmaceutical formulations for treating skin disorders and methods for fabricating and using thereof | |
| CN105106250A (zh) | 一种灵芝总三萜组合物及其制备方法 | |
| Belaiche et al. | Corticosteroid treatment in active Crohn's disease | |
| CN105663063B (zh) | 甘草酸二铵和恩替卡韦的复方微丸片及其制备方法 | |
| CN104546733A (zh) | 一种苯丙哌林掩味微丸 | |
| CN101371825B (zh) | 以丙酸氟替卡松为活性成分的口腔粘贴片 | |
| WO2024041662A1 (zh) | 泊沙康唑固体分散体及其制备方法 | |
| CN101371844B (zh) | 以糠酸莫米松为活性成分的治疗口腔溃疡的粘贴片 |